GlassScriptPhysician profile
Justin Ugwu
NPI 1033537873
$5,169.09
in general payments reported to CMS, 2019-2025
22 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $789 · 2021: $187 · 2022: $654 · 2023: $1,519 · 2024: $206 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.81 |
| Education | $339.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,560.06 | 2019-2025 | Optis, Jeti, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $326.15 | 2019-2022 | |
| Abiomed | $285.25 | 2023 | Impella |
| Chiesi USA, INC. | $258.75 | 2023-2024 | Kengreal |
| Shockwave Medical, INC | $200.87 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $175.21 | 2023-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiovascular Systems INC. | $168.86 | 2022 | |
| Janssen Pharmaceuticals, INC | $167.90 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $124.46 | 2021 | |
| Boston Scientific Corporation | $118.56 | 2019-2020 | |
| Philips North America LLC | $114.66 | 2023 | |
| Penumbra, INC. | $111.06 | 2023 | Indigo System |
| Amgen INC. | $110.38 | 2019-2025 | Repatha |
| Terumo Medical Corporation | $110.15 | 2023 | Angio-Seal, Azur Cx Detachable |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $73.88 | 2023 | Onyx Frontier |
| Heartflow, INC. | $45.99 | 2025 | |
| Biotronik INC. | $45.51 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.93 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.86 | 2025 | |
| Itamar Medical INC | $23.65 | 2023 | Watchpatone |
| Lantheus Medical Imaging, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ugwu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.